期刊文献+

400例抗菌药物不良反应报告分析 被引量:16

Adverse drug reaction analysis of 400 cases induced by antibacterial drugs
暂未订购
导出
摘要 目的探讨该院抗菌药物不良反应(ADR)发生规律及特点,为临床安全用药提供参考。方法对该院2010-2011年收集的400份抗菌药物ADR报告进行回顾性研究,登记ADR名称、级别、结果、药品名称、用药途径、患者年龄、性别、原患疾病。结果 ADR发生集中在40~50岁年龄段,但老年人及儿童发生ADR的比例也较高;其中,静脉滴注297例,占总数74.25%,口服给药96例,占总数24.00%;左氧氟沙星及阿奇霉素ADR发生比例高;ADR临床表现分布广泛,以皮肤及附件损害和消化系统症状为主。结论抗菌药物ADR产生原因较为复杂,广大医务工作者应加强抗菌药物监管,加大对ADR的认识,采取必要干预措施减少或避免ADR的发生。 Objective To analyze the adverse drug reaction(ADR)induced by antibacterial drugs in Yijishan Hospital so as to provide reference for the safety use of drug in clinic.Methods A total of 400 ADR reported cases collected in our hospital from 2010—2011 were analyzed retrospectively,and we recorded the name of ADR,the level of ADR,the result of ADR,the name of drug,the route of administration,the age and the sex of patients and the name of disease.Results The age of patients were mainly in group 40~50,but the incidence of the elderly and the children were relatively high.Among the 400 ADR cases,297 ADR(74.25%)were caused by intravenous route of administration and 96 ADR(24.00%)were caused by oral.The ADR incidences of levofloxacin and azithromycin were high.ADR almost involved all the body system and mainly reflected in the injury of skin and digestive apparatus.Conclusion The reason of ADR induced by antibacterial drugs is complex.Clinical pharmacists should pay more attention to the management of antibiotics.Discovery and treatment is needed as to preventing or avoiding the occurrence of ADR.
出处 《安徽医药》 CAS 2013年第6期1076-1078,共3页 Anhui Medical and Pharmaceutical Journal
关键词 抗菌药物 不良反应 分析 医院药学 合理用药 antibacterial drugs adverse drug reaction analysis hospital pharmacy rational use of drug
  • 相关文献

参考文献11

二级参考文献63

共引文献932

同被引文献150

  • 1国家中医药管理局.中成药临床应用指导原则[S].2010.
  • 2中华人民共和国卫生部.药品不良反应报告和监测管理办法[S].中华人民共和国卫生部令第81号,2011.
  • 3Gallagher RM,Bird KA,Mason JR,et al.Adverse drug reactionscausing admission to a pediatric hospital:a pilot study[J].J Clin Pharm Ther,2011,36(2):194.
  • 4卫生部办公厅.关于做好全国抗菌药物临床应用专项整治活动的通知[Z].卫办医政发[2011]56号,2011-04-18.
  • 5国家食品药品监督管理总局.国家药品不良反应监测年度报告(2013年)[EB/OL].2014-05-14.http://www.sds.gov.en/WS01/CL0078/99794.html.
  • 6廖开成,梁颖茵.舒血宁联合小牛血去蛋白水解物注射液治疗脑梗死疗效分析[J].医药前沿,2013(14):223-224.
  • 7Brotherton TJ, Kelber RL: Seizure-like activity associated with imi- penem[ J]. Clin Pharm,1984,3(5) :536-540.
  • 8Wu Y,Chen K,Shi Z,et al. A Retrospective Study on the Inci- dence of Seizures Among Neurosurgieal Patients who Treated with Imipenem/Cilastatin or Meropenem [ J]. Curt Pharm Biotechnol, 2014,15 (8) :685 - 690.
  • 9Cannon JP, Lee TA, Clark NM, et at. The risk of seizures among the carbapenems : a meta-analysis [ J ]. J Antimierob Chemother, 2014,69 ( 8 ) :2043 - 2055.
  • 10Homik CP, Herring AH, Benjamin DK Jr, et al. Adverse events as- sociated with meropenem versus imipenera/cilastatin therapy in a large retrospective cohort of hospitalized infants [ J]. Infect Dis J, 2013,32(7) :748 -753.

引证文献16

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部